Novo Nordisk A/S: CagriSema demonstrated superior HbA1c
CagriSema achieved superior weight loss of up to 14.2%, where up to 43% of the people achieved ≥15% weight loss...
Nordisk
Novo Nordisk beyond weight loss has investors wary, scientists hopeful
Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. (Photo...
Novo Nordisk fights to keep Medicaid paying for weight-loss drugs
By Dan Levine and Chad Terhune (Reuters) -Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy,...
Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar | Pharmaceuticals industry
Europe’s biggest company, Novo Nordisk, has rebuffed fears of a hit to its business from Donald Trump’s threatened tariffs as...
Novo Nordisk shares tumble as data on weight-loss drug trial disappoints
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Novo Nordisk’s...
Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost
(Repeats Feb 16 story with no changes to text)By Medha Singh and Manas Mishra(Reuters) - U.S.-based Eli Lilly and Denmark's...
